Terug naar events

The Role of Real-World Evidence for Regulatory and Public Health Decision Making for Accelerated Vaccine Deployment

The Role of Real-World Evidence for Regulatory and Public Health Decision Making for Accelerated Vaccine Deployment
EVENT DETAILS
EVENT DETAILS
Date
19 -20 September 2023
Start time
09:30
End time
17:00
Location
Park Inn by Radisson Leuven
Address
Martelarenlaan 36
Leuven
3010
Organizer
IABS & Flanders Vaccine
Website

Real-world evidence meeting organized by IABS and Flanders Vaccine

 

Real-world evidence for monitoring the safety and benefits of vaccination has an essential role to play in the accelerated development and deployment of vaccines. Recently, the COVID-19 pandemic showed the necessity and feasibility of having new vaccines rapidly available. Despite the tremendous success of having several COVID-19 vaccines authorized less than 12 months after the declaration of the COVID-19 global pandemic, many challenges have been faced in both high and low-and-middle income countries. Capitalizing on the massive efforts spent by all stakeholders, it is timely to learn important lessons for the future on how to best use real-world evidence for regulatory and public health decision-making on vaccines and vaccination programmes.

This in-person meeting (Leuven, Belgium) will bring together renowned vaccine experts from national and international public health authorities, regulatory bodies, industry, academia and research organizations for developing recommendations on the best use of real-world evidence for vaccine decision making and a roadmap to further strengthen its use. The meeting brings an exciting mix of information sharing and discussion sessions among all key stakeholders from vaccine development till deployment.

Check out the complete program here

Programme Flanders Vaccine Session- Wednesday 20 of September, 2023 

SESSION 6: Experiences using RWE for health economics & for regulatory and public health decision-making on non – COVID-19 vaccines

14:00    Welcome – Flanders Vaccine

14:05    Exploring the Cost-Effectiveness of Respiratory Syncytial Virus (RSV) Preventive Interventions in children with Real-World Evidence (IMI-RESCEU project) – Xiao Li, Health economist, University of Antwerp, Belgium

14:30    Public Health Impact and Return on Investment of Belgium’s Pediatric Immunization Program – Olivier Ethgen, Professor Health Economics, Université de Namur & André Bento, Associate Director, HEOR Manager at MSD

14:55  PERCH (PartnERship to Contrast HPV) project – Hélène De Pauw, Scientist at the Unit of Cancer Epidemiology, Belgian Cancer Centre, Sciensano

15:20    Coffee break

15:50  Health information for policy & decision-making on vaccination – Laura Cornelissen, Scientific Expert and team leader for vaccine-preventable diseases, Department of epidemiology of infectious diseases, Sciensano

16:15  Improving quality of evidence for decision making through innovative design and collaborative studies leveraging RWE platformsLaurence Torcel- Pagnon, Global Medical Evidence Generation Lead Influenza, Sanofi, Lyon, France

16:40  Closing

 

Click on the following link to consult the SCIENTIFIC AGENDA and REGISTRATIONS: Real-world-evidence-meeting-2023

 

 

 

 

Sponsors